Created at	Source	Raw Value	Validated value
March 30, 2021, 7:20 a.m.	eu	The percentage of individuals in each treatment group reaching seroconversion i.e. 4-fold increase in anti-spike IgG and controls 2-6 weeks following vaccination,	The percentage of individuals in each treatment group reaching seroconversion i.e. 4-fold increase in anti-spike IgG and controls 2-6 weeks following vaccination,